Curcumin-the yellow magic

Asian Journal of Applied Sciences

Volumn 4, Issue 4, 2011, Pages 343-354

  Pandey, Archana ^a   Gupta, Ravindra Kumar ^a   Srivastava, Roli ^a  

^a University of Allahabad   (India)

Author keywords

Alzheimer disease; Anticancer activity; Antioxidant property; Curcumin; Therapeutic effects

Indexed keywords

EID: 79961099279     PISSN: 19963343     EISSN: None     Source Type: Journal    
DOI: 10.3923/ajaps.2011.343.354     Document Type: Review

References (84)

1. Adams, B.K., J. Cai, J. Armstrong, M. Herold and Y.J. Lu et al., 2005. EF24, a novel synthetic curcumin analog,induces apoptosis in cancer cells via a redox-dependent mechanism. Anticancer Drugs, 16: 263-275.
2. Ammon, H.P., H. Safayhi, T. Mack and J. Sabieraj, 1993. Mechanism of anti-inflammatory actions of curcumin and boswellic acid. J. Ethnopharmacol., 38: 113-119.
3. Ao, C., A. Li, A.A. Elzaawely and S. Tawata, 2008. MMP-13 Inhibitory activity of thirteen selected plant species from okinawa. Int. J. Pharmacol., 4: 202-207.
4. Arora, R.B., N. Basu, V. Kapoor and A.P. Jain, 1971. Anti-inflammatory studies on Curcuma longa (Turmeric). Indian J. Med. Res., 59: 1289-1295.
5. Balogun, E., M. Hoque, P. Gong, E. Killeen and C.J. Green et al., 2005. Alteration of the Nrf2-Keap1 interaction enables Nrf2 to translocate to the nucleus, bind to the Antioxidant-Responsive Element (ARE) and initiate the transcription of genes coding. Biochem. J., 371: 887-895.
6. Banerjee, S., G. Bandyopadhyaya, K. Chattopadhyay and B.D. Chattopadhyay, 2010. Amelioration of nicotine-induced damage of blood cells in protein malnourished female rats by curcumin. Int. J. Pharmacol., 6: 444-455.
7. Baun, L. and A. Ng, 2004. Curcumin interaction with cupper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. J. Alzheimers Dis., 6: 367-377.
8. Berger, A.C., P.A. Randak, P.B. Cahill, N. Choe, S. Canny, C.A. Wagner and I. Geibel, 2002. Curcumin pump inhibitors induce functional surface expression of Detta F 508-CFTR protein in cystie fibrosis epithelial cells. Nat. Med., 8: 485-492.
9. Bharat, B.A., 2007. Curcumin-Biological and Medical Properties. In: Turmeric: The Genus Curcuma: Medical and Aromatic Plants Industrial Profiles, Ravindran, P.A., K.N. Babu and K. Sivaraman (Eds.). CRC Press, Boca Raton, FL.
10. Brouet, I. and H. Obshima, 1995. Curcumin an antitumour promoter and anti-inflammatory agent inhibit induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun., 206: 533-540.
11. Calabrese, V., D.A. Butterfield and G. Stella, 2003. Nutrional antioxidants and the heme oxygenase pathway of stress tolerance, novel targets for neuroprotection in Alzheimer disease. Ital. J. Biochem., 52: 177-181.
12. Chai, H., S. Yan, P. Lin, A.B. Lumsden, Q. Yao and C. Chen, 2005. Curcumin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine coronary arteries. J. Am. Coll. Surg., 200: 820-830.
13. Chakravarty, A.K., S.N. Chatterjee, H. Yasmin and T. Mazumder, 2009. Comparison of efficacy of turmeric and commercial curcumin in immunological functions and gene regulation. Int. J. Pharmacol., 5: 333-345.
14. Chattopadhyay, I., K. Biswas, U. Bandyopadhyay and R.K. Banerjee, 2004. Turmeric and curcumin: Biological actions and medicinal applications. Curr. Sci., 87: 44-53.
15. Chen, H., Z.S. Zhang, Y.L. Zhang and D.Y. Zhou, 1999. Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinomacells. Anticancer Res., 19: 3675-3680.
16. Chuang, S., A. Cheng, J. Lin and M. Kuo, 2000. Inhibition by curcumin of diethylnitrosamine induced hepatic hyperplasia inflammation celluler gene products and cell cycle related proteins in rats. Food Chem. Toxicol., 38: 991-995.
17. Chuang, S.E., M.L. Kuo, C.H. Hsu, C.R. Chen and J.K. Lin et al., 2000. Curcumin containing diet inhibits diethylnitrosemin induced murine hepato carcinogenesis. Carcinogenesis, 21: 331-335.
18. Chuang, S.E., P.Y. Yeh, Y.S. Lu, G.M. Lai, C.M. Liao, M. Gao and A.L. Cheng, 2002. Basal levels and patterns of anticancer drug-induced activation of unclean factor-kappa B (NF-Kappa B) and its attention by tamaxifen, dexamethasone and curcumin in cancinoma. Cells Biochem. Pharmacol., 63: 1709-1716.
19. Daniel, S., J.L. Limson, A. Dairam, G.M. Watkins and S. Daya, 2004. Through metal binding, curcumin protects against lead-and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain. J. Inorg. Biochem., 98: 266-275.
20. Daube, F.V., 1870. Uber curcumin, den farbstoff der curcumawurzel. Berichte Deutschen Chemischen Gesellschaft, 3: 609-613.
21. De, R., P. Kandu, S. Swarnaka, T. Ramamurthy, A. chowdhry, G.B. Nair and A.K. Mukhopadhyay, 2009. Antimicrobial activity of curcumin against helicobacter pylori isolate from India and during infections in mice. Antimicrobial Agent Chemother., 53: 1592-1597.
22. Deodhan, S.D., R. Sethi and R.C. Srimal, 1980. Preliminary study on anti rheumative activity of curcumin (Diferuloylmethane). Ind. J. Med. Res., 71: 632-634.
23. Deshpande, S.S., A.D. Ingle and G.B. Maru, 1998. Chemopreventive efficacy of curcumin free aqueous turmeric extract in 7, 12-dimethylbenzanthracene induced rat mammary tumorigenesis. Cancer Lett., 123: 35-40.
24. Egan, M.E., M. Pearson, S.A. Weiner, D. Rajendra and P.J. Rusin et al., 2004. Curcumin, a major constituent of turmerie, corrects eystie fibrosis defects. Science, 304: 600-602.
25. Foda, M.I., M. Abd El-Aziz and A.A. Awad, 2007. Chemical, rheological and sensory evaluation of yoghurt supplemented with turmeric. Int. J. Dairy Sci., 2: 252-259.
26. Garcea, G., D.J. Jones, R. Singh, A.R. Dennison and P.B. Farmer et al., 2004. Detection of curcumin and its metabolites in hepatie lissue and portal blood of partients following oral administration. Br. J. Cancer, 90: 1011-1015.
27. Garcea, G., D.J.L. Jones, D.P. Berry, A.R. Dennison and P.B. Farmer et al., 2005. Consumption of the putative chemopreventive agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodyhamic consequences. Cancer Epidemiol. Biomarkers Prev., 14: 120-125.
28. Ghatak, N. and N. Basu, 1972. Sodium curcuminate as an effective anti-inflammatory agent. Ind. J. Exp. Biol., 10: 235-236.
29. Hiroshi, I., O. Makoto, I. Naoshi, K. Megumi and K. Yasuhiro et al., 1999. Chemoprevention by curcumin during the promotion stage of tumor genesis of mammary gland in rats irradiated with γ-rays. Carcinogenesis, 20: 1011-1018.
30. Huang, M.J., R.C. Smart, C.Q. Wong and A.H. Convey, 1988. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res., 48: 5941-5946.
31. Huang, M.T., M.W. Loyr, H.L. Newmark, K.R. Riuhla nd A.H. Conney, 1994. Inhibitory effect of dietary curcumin on fore stomach, duodenal and colon carcinogenesis in mice. Cancer Res., 54: 5841-5847.
32. Huang, M.T., Y.R. Lou and I.G. Xie et al., 1998. Effect of dietary curcumin and dibenzoylmethane on formation of 7, 12-dimethlbenz [a] anthraeene-induced mannary tumors and lymphomas/leukemias in sencar mice. Carcinogenesis, 19: 1697-1700.
33. Ikezaki, S., N.A. Shikawa, F. Furukawa, K. Kudo, H. Nakamura, K. Tamura and H. Mori, 2001. Chemo preventive effect of curcumin on glandular stomach carcinogenesis induced by N-methyl-N, nitro-N-nitro soguanidine and sodium chloride in sats. Anticancer Res., 21: 3407-3411.
34. Karunagaran, D., R. Rashmi and T.R. Kumar, 2005. Induction of apoptosis by curcumin and its implications for cancer therapy. Curr. Cancer Drug Targets, 5: 117-129.
35. Kawamori, T., R. Lubet, V.E. Steele, G.J. Kelloff, R.B. Kaskey, C.V. Rao and B.S. Reddy, 1999. Chemopreventive effect of curcumin a naturally occurring anti-inflammatory agent during the promotion progression stages of colon cancer. Cancer Res., 59: 597-601.
36. Khopde, S.M., K.I. Priyadarshini, P. Venkatesan and M.N. Rao, 1999. Free radical scavenging ability and antioxidant efficiency of curcumin and its substituted analogue. Biophys. Chem., 80: 83-89.
37. Krishnaswamy, K., V.K. Goud, B. Sesikeran, M.A. Mikundan and T.P. Krishna, 1998. Retardation of experimental tumorigensis and reduction in DNA adducts by turmine and curcumin. Nutr. Cancer, 30: 163-166.
38. Kuttan, R., P. Bhanumathy, K. Nirmala and M.C. George, 1985. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett., 29: 197-202.
39. Kuttan, R., P.C. Sudheeran and C.D. Joseph, 1987. Turmeric and curcumin as topical agents in cancertherapy. Tumori, 73: 29-31.
40. Lee, S.L., W.J. Huang, W.W. Lin, S.S. Lee and C.H. Chen, 2005. Preparation and anti-inflammatory activities of diarylheptanoid and diarylheptylamine analogues. Bioorg. Med. Chem., 13: 6175-6181.
41. Li, C.I., L.J. Zhang, B.J. Dezube, C.S. Crumpacker and A.B. Pardee, 1993. Three inhibitions of type 1 immune deficiency virus long terminal repeat-directed gene expression and virus replication. Proc. Natl. Acad. Sci. USA., 90: 1839-1842.
42. Li, N., X. Chen, J. Liao, G. Yang and S. Wang et al., 2002. Inhibition of 7, 12-di-methylbenz anthracene (DMBA) induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis, 23: 1307-1313.
43. Limtrakul, P., S. Lipigorngoson, O. Namwong, A. Apisariyakul and F.W. Dunn, 1997. Inhibitory effect of dietary curcumin on skin creinogenesis in mill. Cancer Lett., 116: 197-203.
44. Mahmoud, N.N., A.M. Carothers, D. Grunberger, R.T. Bilinski and M.R. Churchill et al., 2000. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis, 21: 921-927.
45. Mall, M. and K. Kunzelmann, 2005. Correction of the CF defect by curcumin: Hypes and disappointments. BioEssays, 27: 9-13.
46. Milobedzka, J., S. von Konstanecki and V. Lampe, 1910. Zur kenntnis des curcumins. Ber. Dtsch. Chem. Ges., 43: 2163-2170.
47. Motterlini, R., R. Foresti, R. Bassi and C.J. Green, 2000. Curcumin an antioxidant and anti-inflammatory agent induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic. Biol. Med., 28: 1303-1312.
48. Mukopadhyaya, A., N. Basu, N. Ghatak and P.K. Gujral, 1982. Anti-inflammatory and irritant activity of curcumin analogues in rats. Agents Actions, 12: 508-515.
49. Natarajan, C. and J.J. Bright, 2002. Curcumin inhibits EAE by blocking IL-12 signaling through Janes kinase-STAT pathway in T-lymphocytes. J. Immunol., 168: 6506-6513.
50. Ono, K., K. Hasegawa, H. Naiki and M. Yamada, 2004. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta amyloid fibrils in vitro. J. Neurosci. Res., 75: 742-750.
51. Padhye, S., S. Banerjee, D. Chavan, S. Pandey and K.V. Swamy et al., 2009. Fluorocurcumin as cyclooxygenase-2 inhibitors: Molecular docking, pharmacokinetic and tissue distribution in mice. Pharm. Res., 26: 2438-2445.
52. Pandey, A., V. Dwivedi and K. Mishra, 2010. Drug sensitivity of curcumin analogues and bioconjugates. Bio Active Nat. Prod., 7: 267-298.
53. Pereira, M.A., C.I. Grubbs, L.H. Barnes, H. Li and G.R. Olson et al., 1996. Effects of the phyto chemicals, curcumin and quen cetin, upon azoxy methane induced colon cancer and 7, 12-dimethylbenz anthracene induced mammary cancer in rats. Carcinogenesis, 17: 1305-1311.
54. Perkins, S., R.D. Verschoyle, K. Hill, I. Parveen and M.D. Threadgill et al., 2002. Chemopreventive efficacy and pharmalokinlties of curcumin in the min/+ mouse, a model of fan dial adevomatous polypsis. Cancer Epidemiol. Biomarkers Prev., 11: 535-540.
55. Piper, J.T., S.S. Singhal, M.S. Salameh, R.T. Torman, Y.C. Awasthi and S. Awasthi, 1998. Mechanisms of anti carcinogenic properties of curcumin the effect of curcumin on situation linked detoxification enzymes in rat liver. Int. J. Biochem. Cell Biol., 30: 445-456.
56. Plummer, S.M., K.A. Holloway, M.M. Manson, R.J. Munks, A. Kaptein, S. Farrow and L. Howells, 1999. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene, 18: 6013-6020.
57. Priyadarsini, K.I., D.K. Maity, G.H. Naik, M.S. Kumar, M.K. Unnikrishnan, J.G. Satav and H. Mohan, 2003. Role of phenolic OH and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radic. Biol. Med., 35: 475-484.
58. Rai, D., J.K. Singh, N. Ray and D. Panda, 2008. Curcumin inhibits FtsZ assembly: An attractive mechanism for its antibacterial activity. Biochem. J., 410: 147-155.
59. Rao, C.V., A. Rivenson, B. Simi and B.S. Reddy, 1995. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res., 55: 259-266.
60. Rao, D.S., N.C. Shekhra, M. N. Satyanarayana and M. Srinivasan, 1970. Effect of curcumin on serum and liver cholesterol levels in the rat. J. Nutr., 10: 1307-1315.
61. Rao, T.S., N. Basu, S.D. Seth and H.H. Siddiqui, 1984. Some aspects of pharmacological profile of sodium curcuminate. Ind. J. Physiol. Pharmacol., 28: 211-215.
62. Satoskar, R.R., S.J. Shah and S.G. Shenoy, 1986. Evaluation of anti-inflammatory propriety of curcumin in patients with post-operative inflammation. Int. J. Clin. Pharmacol. Ther. Toxicol., 24: 651-654.
63. Shankar, T.N.B. and V.S. Murthy, 1979. Effect of turmeric (Curcuma longa) fractions on the growth of some intestinal and pathogenic bacteria in vitro. Ind. J. Exp. Biol., 17: 1363-1366.
64. Sharma, R.A., A.J. Gescher and W.P. Steward, 2005. Curcumin: The story so far. Eur. J. Cancer, 41: 1955-1968.
65. Sharma, R.A., B. Mcclelland, H.R. Hill, C.A. Ireson and C.R. Euden et al., 2001. Pharmaeodynemics and pharmacokinetics study of oral curcuma extract in patient's with colorectal cancer. Clin. Cancer Res., 7: 1894-1900.
66. Sharma, R.A., C.R. Ireson, R.D. Verschoyle, K.A. Hill and M.L. Williams et al., 2001. Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: Relationship with drug levels. Clin. Cancer Res., 7: 1452-1452.
67. Si, X., Y. Wang, J. Wong, J. Zhang, B.M. McManus and H. Luo, 2007. Dysregulation of the ubiguitin-proteasome system by curcumin suppresses coxsackievisus B3 replication. J. Virol., 81: 3142-3150.
68. Simanjuntak, P., T.K. Prana, D. Wulandari, A. Dharmawan, E. Sumitro and M.R. Hendriyanto, 2010. Chemical studies on a curcumin analogue produced by endophytic fungal transformation. Asian J. Applied Sci., 3: 60-66.
69. Singletary, K., C. IM. Macdonald, C. Fisher and M. Wallig, 1998. Effect of the beta-dike tones diferuloylmethane (curcumin) and dibenzoylmethance on rat mammary DNA aducts and tumors induced by 7, 12-dimethylbenz antaracene. Carcinogenesis, 19: 1039-1043.
70. Soni, K.B. and R. Kuttan, 1992. Effect of oral curcumin administration or serum peroxides and cholesterol levels in human volunteers. Ind. J. Physiol. Phanmacol., 36: 273-275.
71. Soudamini, K.K., M.C. Unnikrishnan, Soui, K.B. and R. Kuttan, 1992. Inhibition of lipid per oxidation and cholesterol levels in mice by curcumin. Ind. J. Pysiol. Pharmacol., 36: 239-243.
72. Srimal, R.C. and N. Dhawan, 1973. Pharmacology of diferuloylmethane (Curcumin) a non-steroidal anti-inflammatory agent. J. Pharma. Pharmacol., 25: 447-452.
73. Suryanarayana, P., M. Saraswat, T. Mrudula, T.P. Krishna, K. Krishnaswamy and G.B. Reddy, 2005. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest. Ophthalmol. Vis. Sci., 46: 2092-2099.
74. Suryanarayana, P., S.K. Krishna and G.B. Reddy, 2003. Effect of curcumin on galactose induced cataraetogenesis in rats. Mol. Vis., 9: 223-230.
75. Tajik, H., E. Tamaddonfard and N. Hamzeh-Gooshchi, 2007. Interaction between curcumin and opioid system in the formalin test of rats. Pak. J. Biol. Sci., 10: 2583-2586.
76. Tajik, H., E. Tamaddonfard and N. Hamzeh-Gooshchi, 2008. The effect of curcumin (Active Substance of Turmeric) on the acetic acid-induced visceral nociception in rats. Pak. J. Biol. Sci., 11: 312-314.
77. Tanaka, Y., H. Kobayashi, M. Suzuki, N. Kanayama and T. Terao, 2004. Transforming growth factor-β1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells. J. Biol. Chem., 279: 8567-8576.
78. Toshiya, M.M., H. Tomomi, B. Kayo, T. Hiromi and Y. Yoshio, 2001. New developments in antioxidants research. J. Agric. Food Chem., 49: 2539-2547.
79. Ushida, J., S. Sugie, K. Kawabata, Q.V. Pham and T. Tanaka et al., 2000. Chemopreventive effect of curcumin on N-nitrosomethyl benzylamine induced esophageal carcinogenesis in rats. Jpn. J. Cancer Res., 91: 893-898.
80. Verbeek, R., E.A. van Tol and J.M. van Neort, 2005. Oral flavonoids delay recovery of from experimental auto immune encephatomyelitis in SJL mice. Biochem. Pharmacol., 70: 222-228.
81. Vogel and Pelletier, 1818. 10 Curcumin-biological and medicinal properties. J. Pharma., 2: 50-50.
82. Ward, C.L., S. Omura and R.R. Kopito, 1995. Degeneration of CITR by the ubiquitin-proteasome pathway. Cell, 83: 121-127.
83. Weber, W.N., L.A. Hunsaker, S.F. Abcouwer, L.M. Deck and J.D.L. Vander, 2005. Antioxidant activities of curcumin and related enones. Bioorg. Med. Chem., 13: 3811-3820.
84. Yang, F., G.P. Lim, A.N. Begum, O.J. Ubeda and M.R. Simmons et al., 2005. Curcumin inhibits formation of amyloid beta oligomers and fibrils, bind plaques and reduce amyloid in vivo. J. Biol. Chem., 280: 5892-5901.